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Abstract 
 
Background. Tourette syndrome (TS) is a neurodevelopmental condition characterised by multiple tics and co-
morbid behavioural problems. Previous research found that up to 76% of patients with TS experience affective 
symptoms, with 13% fulfilling diagnostic criteria for depression.   
Objectives. We aimed to assess the severity of depression and profile of depressive symptoms in adult patients 
with TS compared to patients with major depression and healthy controls. 
Methods. Depression ratings were collected from patients with TS (N=65) using the BDI-II and from patients 
with recurrent major depressive disorder (rMDD, N=696) and healthy controls (N=293) using the Beck 
Depression Inventory (BDI)-IA. Direct comparisons were possible for 14/21 BDI items.  
Results. Patients with TS scored significantly higher on the BDI than controls (P<.001) and all individual 
symptoms were reported more frequently by patients with TS than by controls (P<.001). Total BDI score in TS 
was not significantly different to that in rMDD, however irritability was significantly more frequently reported 
in the TS group and this remained significant after controlling for age and gender differences between the two 
groups (OR 5.24, 95% CI 1.97-14.00; P=.001).  
Conclusions. Our findings show that depression is a prominent feature in TS and may present with a more 
irritable phenotype than rMDD. Patients with TS should be routinely screened for depression to implement 
treatment as appropriate. 
 
Key Words: Tourette syndrome; Tics; Affective disorders; Depression; Irritability. 
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1. INTRODUCTION 
 
Tourette syndrome (TS) is a neurodevelopmental disorder characterised by multiple motor and phonic tics [1]. 
TS is estimated to affect up to 1% of children and adolescents, as well as adults in a less severe form [2]. 
Symptoms wax and wane in severity over weeks, months and years, but over time patients usually show marked 
reductions in their symptoms [3], regardless of treatment [4]. 
 
TS is associated with a spectrum of behavioural co-morbidities in about 90% of patients [5], particularly 
attention-deficit and hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), impulse control 
disorders and affective disorders [6]. Evidence from both controlled and uncontrolled studies suggest that 
depression is prevalent in TS, with an epidemiological meta-analysis estimating that 13% of patients with TS 
fulfil diagnostic criteria for depression and 76% experience sub-threshold depressive symptoms [7]. In a large 
population-based cohort study conducted on 1337 patients with TS, the risk of developing depression was about 
5 times higher in the TS population compared to the control cohort [8]. 
 
In a sample of children and adolescents with TS, it was found that the presence of affective disorders 
significantly predicted psychiatric hospitalisation [9]. Moreover, a number of studies showed that depression is 
associated with significant impairments to health-related quality of life [10,11], in both children [12,13] and 
adults [14,15] with TS. Recent research has suggested that depressive symptoms, alongside anxiety, moderate 
the relationship between tic severity and functional impairment in adult patients with chronic tic disorders [16].  
Despite extensive research into the behavioural symptoms in young patients with TS, relatively little is known 
about the clinical presentation of depressive symptoms in adults with TS, apart from a recently identified 
association between co-morbid depression and increased values of the ‘threatened self’ or  narcissistic 
vulnerability [17]. 
 
The aim of this study was to examine the severity of depression and phenomenology of depressive symptoms in 
adults with TS in comparison to patients with major depression and healthy controls. We anticipated to find 
higher depressive symptom severity in patients with TS than healthy controls and partially overlapping affective 
profiles between TS and major depression, in line with the documented presence of mood disorder and 
suicidality in patients with ‘malignant’ TS [18]. This is of particular relevance to clinical practice, as adult 
patients with TS have been shown to have a greater prevalence of mood disorders than children with TS [19]. 
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2. METHODS 
 
All consecutive adult patients attending the specialist TS clinic at the Department of Neuropsychiatry, BSMHFT 
and University of Birmingham, UK, were invited to take part in this study. Patients with a lifetime diagnosis of 
recurrent major depressive disorder (rMDD) and healthy controls were recruited by the multi-centre (Cardiff 
and Birmingham, UK) Mood Disorders Research Group (MDRG) as part of an ongoing programme of research 
into the genetic and non-genetic determinants of affective disorders [20]. The MDRG recruited patients with 
affective disorders and controls via Community Mental Health Teams across the UK and advertisements 
through GP surgeries, patient support organisations (e.g., Depression Alliance) and local media.  Patients with 
rMDD were recruited when they were judged by their medical team to be well enough to participate. The 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision (DSM-IV-TR) criteria 
were used for the diagnosis of TS [21], whereas the DSM-IV criteria were applied to the rMDD group [22]. 
Patients with rMDD were recruited when relatively well and the healthy controls had no personal or family 
history of psychiatric illness. The studies received both local and national ethics approval and informed consent 
was obtained from each participant. 
 
The demographic and clinical data of the patients with TS were gathered from participants’ medical records. 
Each patient underwent a comprehensive clinical assessment using the National Hospital Interview Schedule for 
TS (NHIS-TS) [23]. The NHIS-TS is a detailed semi-structured interview schedule which covers personal and 
family histories and demographic details. For the diagnosis of various TS-associated psychiatric disorders, the 
NHIS-TS was originally developed by incorporating the relevant questions and items from the Diagnostic 
Interview Schedule and WHO criteria to yield a lifetime diagnosis as per DSM-III-R and ICD-10, and was 
subsequently updated based on the DSM-IV-TR criteria. The treating clinician (AEC) ascertained lifetime 
recurrent major depression. The Yale Global Tic Severity Score (YGTSS) [24] and the Diagnostic Confidence 
Index (DCI) [25] were completed as ratings of tic severity and lifetime cumulative symptomatology, 
respectively. Both the YGTSS and DCI scores range from 0 to 100, with higher scores indicating higher tic 
severity and diagnostic confidence of TS. 
 
The 21-item Beck Depression Inventory (BDI) is a widely used self-report scale which measures the 
psychological and biological symptoms of depression over the week prior to completion. The first edition (BDI-
IA) was amended to simplify the scoring structure [26], with the second edition (BDI-II) subsequently 
developed to reflect DSM-IV criteria for affective disorders [27]. A study comparing self-report scales for 
affective symptoms proposed the BDI-II as the instrument of choice for assessing depression in patients with TS 
[28]. In our study, all patients with TS completed the BDI-II, whilst patients with rMDD and controls completed 
the BDI-IA, as their recruitment preceded the enrolment of patients with TS. In developing the BDI-II, 4 items 
(self-image, occupational functioning, weight loss and hypochondriasis) were removed from the original BDI-
IA list and replaced with questions addressing agitation, feelings of worthlessness, loss of energy and 
concentration difficulty. These items were excluded from our analysis, along with the items on self-dislike, 
sleeping pattern and appetite, because the scoring anchor points were different between the two BDI versions. 
The remaining 14 items had minor wording changes with intact anchor points, which allowed reliable 
comparisons of symptom severity. Total BDI-II scores from the TS sample were converted to BDI-IA scores 
using the recommended equipercentile equating method [27]. With scoring adjustments, the BDI-IA and BDI-II 
self-reports have previously been compared in psychiatric outpatients [29]. In the present study, to compare the 
frequency of different BDI items across the diagnostic groups, we assigned ‘0’ and ‘1’ responses as non-
clinically significant (‘absent’), with ‘2’ and ‘3’ being clinically significant (‘present’).            
 
Statistical analyses were performed using the SPSS statistical package version 20.0 (IBM, Armonk, NY, USA). 
Continuous variables (e.g., total BDI score) were compared between diagnostic groups using Kruskal-Wallis 
tests (KWH) followed by pairwise post-hoc comparisons using Mann-Whitney tests (MWU). Categorical 
variables (e.g., presence/absence of each BDI symptom) were compared between diagnostic groups using 
Χ2/Fisher’s exact tests. Within group associations between continuous variables (e.g., between total BDI score 
and age) were explored using correlation analyses (Spearman’s rho; ρ). The Bonferroni method was used to 
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adjust the cut-off for a significant P value to .025 and control for α-inflation by multiple testing. We also carried 
out logistic regression analyses (enter method) to explore i) whether BDI total score and ii) which combination 
of BDI symptoms was/were associated with diagnostic group after controlling for demographic differences 
between groups (gender, age).  
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3. RESULTS 
 
A total of N=1054 participants were included in the study. Demographic data for the three groups are illustrated 
in Table 1. The TS group was significantly younger (KWH=106.03, P<.001), and comprised significantly more 
males X
2
=58.26, P<.001), than the rMDD and control groups, reflecting the higher male:female ratio in TS 
populations. The vast majority of participants in all groups were White British.  
 
 
 
 
Table 1. Demographic characteristics of the study participants. 
 
 
 
 
Abbreviations: TS, Tourette syndrome; rMDD, recurrent major depressive disorder 
 
 
 
 
The TS group was representative of a clinic population with characteristic symptoms (median TS DCI score 
68.0% [range 33.0-100.0]) and moderate-to-marked tic severity (median YGTSS tic severity score 25.0/50 
[range 11.0-46.0], with overall impairment score 20.0/50 [range 10.0-50.0]). Co-morbid diagnoses included 
depression (40.0%), ADHD (24.6%), OCD (23.1%, with 49.2% of patients presenting obsessive-compulsive 
symptoms of different degrees of severity) and bipolar disorder (7.7%). With regards to pharmacotherapy, 
patients were mainly treated with neuroleptics (46.2%), clonidine (21.5%) and antidepressants (30.8%). A 
family history of affective disorders was present in 24.6% of patients with TS. 
 
As illustrated by Figure 1A, there was a significant difference in total BDI score across diagnostic groups 
(KWH=411.52, P<.001). Pairwise comparisons between TS and control and rMDD groups identified a 
statistically significant difference between TS and controls (P<.001) with TS patients scoring significantly 
higher than controls, but not between TS and rMDD (P=.030). Figure 1B illustrates the frequencies of 
participants reporting the presence of each BDI symptom in each diagnostic group. There was a significant 
difference between groups for every symptom (all P<.001). Pairwise X
2
 comparisons showed significantly 
higher reporting of every symptom in the TS and rMDD groups compared to controls (all P<.001). When 
comparing the TS and the rMDD groups, the only significant differences were that sadness (P=.005) and loss of 
libido (P=.008) were more frequently reported in the rMDD group, and irritability (P=.006) was more 
frequently reported in the TS group.  
 
Logistic regression showed that, after controlling for age and gender, total BDI score was predictive of a 
diagnosis of TS compared to controls (odds ratio [OR] 1.50, 95% confidence intervals [CI] 1.33-1.69; P<.001), 
but not compared to rMDD. Further analysis showed that, after controlling for age and gender, the only BDI 
symptom that predicted TS compared to rMDD was irritability (OR 5.24; 95% CI 1.97-14.00; P=.001).   
 
 
 Controls TS
 
rMDD 
N (% female) 293 (60.8) 65 (32.3) 696 (71.7) 
Age – median 
(range) years  
50.0 (24.0-63.0) 26.0 (16.0-65.0) 48.0 (18.0-65.0) 
Ethnicity – %     
White British 100.0 89.2 97.7 
White Other - 3.1 2.2 
Asian - 6.2 - 
African - 1.5 0.1 
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Figure 1. Comparison of median total BDI scores (A) and frequency of reporting individual BDI symptoms (B) 
across three diagnostic groups: healthy controls, Tourette syndrome (TS) and recurrent major depressive 
disorder (rMDD). 
 
A 
 
B 
 
 
*TS-rMDD pairwise comparison P=.03 
**TS-rMDD pairwise comparison P=<.01 
***TS-healthy controls pairwise comparison P<.01 
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4. DISCUSSION 
 
This is the largest study to date to explore depressive symptoms in adult patients with TS in comparison to 
patients with major depression and healthy controls. Gender ratios in our patient populations were representative 
of clinical samples, with male predominance in TS and female predominance in major depression [2,30]. 
According to our results, patients with TS reported higher depressive scores than healthy controls, and their 
scores were comparable to patients with a primary diagnosis of recurrent major depression.  
 
Previous studies employing a variety of clinical rating scales for depression in child, adolescent and some adult 
cohorts have consistently found higher scores in patients with TS compared to healthy controls [31-37]. Only 
one study examining N=17 children and adolescents with TS and an equal number of age and sex-matched 
control subjects failed to find consistent group differences on the Children’s Depression Inventory scores, 
although the TS group reported higher scores on the depression sub-scale of the Child Behavior Checklist [38]. 
The results of this isolated study are to be interpreted in the light of the known differences between self- and 
proxy-ratings in young patients with TS [39-41]. 
 
The present study validates the findings of a previous smaller study, in which adult patients diagnosed with TS 
(N=22) and depression (N=19) were compared to healthy controls (N=21) across a variety of psychopathological 
indices, including depression ratings [42]. Post hoc analyses indicated that both patients with TS and patients 
with depression experienced more severe depressive symptoms than controls, and in turn patients with 
depression had higher scores than those with TS (all P<.0001). Besides the considerable difference in sample 
size, the recruitment setting (psychiatric outpatient clinics only) suggests that patients with more severe forms of 
depression were included in the patient control group of this earlier study. It is therefore not surprising that he 
difference between the TS and depressed groups was not replicated in our study (adjusted P value was trend-
level significant only). 
 
The presence of depressive symptoms in TS is likely to have a multifactorial aetiology, which includes the 
psychological consequences of having a socially disabling and chronic condition, the high co-morbidity rate 
with ADHD and OCD, the side-effects of pharmacotherapy for tics and associated co-morbidities, the family 
history for tics and/or behavioural problems, shared biological risk factors for both disorders and the possibility 
of chance co-morbidity, as both depression and TS are relatively common disorders [7]. 
 
Our results also highlight the prominence of irritability in TS compared to the rMDD group. Impulse control 
disorders, including aggressive behaviours, rage attacks and conduct problems, are frequently reported in TS 
[43,44] and usually related to the presence of co-morbid ADHD [45-47]. Given that irritability is a common 
feature of neuropsychiatric disorders [48], this may be independent of depression and due to TS-related factors 
[49]. However, our findings raise the possibility that irritability could act as a mediator between affective 
disturbances and impulse dyscontrol, especially in patients with TS who also have a diagnosis of ADHD. 
 
Our study has limitations. Firstly, the study design was cross-sectional, and future studies would benefit from 
implementing a prospective design in order to capture the development of depressive features. Secondly, the 
healthy control group was ‘super-normal’, i.e. without any personal or family history of psychiatric disorders, 
which maximised the chances of finding differences between controls and patient groups. Thirdly, there may be 
some discrepancy with different versions of the BDI used, although the conversion of BDI-II to BDI-IA was 
validated by previous research by the BDI developers. Fourthly, the fact that no data about antidepressant use 
were available for analysis from the rMDD group could be a relevant confounder, as irritability symptoms have 
been shown to be potentially responsive to antidepressants, as well as antipsychotics and mood stabilisers [50]. 
Finally, the TS group was recruited from a specialist clinic within a tertiary care setting, and due to referral bias 
might not be representative of the overall TS population. 
 
In conclusion, depression appears to be a prominent feature in TS, particularly the symptom of irritability which 
may be related to aggressive symptoms and impulse dyscontrol, often reported by patients with TS and co-
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morbid ADHD. We therefore suggest that patients with TS should be routinely screened for specific depressive 
symptoms in order to provide appropriate management of psychological and behavioural problems. 
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Highlights 
 
We assessed depressive symptoms in adults with Tourette syndrome (TS) and controls. 
 
TS patients reported similar depressive scores to patients with major depression. 
 
Both patient groups reported higher depressive scores than healthy controls. 
 
TS patients presented with irritability features in association with depression. 
 
TS patients should be routinely screened for depression to implement treatment. 
